Assessment of the hepatoprotective effect of Ich can thanh oral solution on an experimental model of ethanol-induced hepatitis
Main Article Content
Abstract
The present study assessed the hepatoprotective effects of Ich can thanh oral solution in Swiss mice with ethanol-induced hepatitis. Mice received ethanol orally daily, with weekly increased concentrations (10%, 20%, 30%, 40%). One hour after ethanol administration, mice were given distilled water, Ich can thanh, or silymarin for four weeks. All parameters, including body weight, liver weight, blood biochemical markers (AST, ALT, GGT, albumin, and total bilirubin), liver malondialdehyde levels, glutathione concentration, and histopathological analysis, were evaluated. The results indicated that Ich can thanh at 4.8 mL/kg/day showed a trend toward hepatoprotection against ethanol-induced chronic hepatitis in mice. At 9.6 mL/kg/day, Ich can thanh significantly increased body weight, reduced liver weight, decreased serum liver enzyme levels, and attenuated oxidative stress compared to the control group. Additionally, Ich can thanh improved the histopathological features in mice with ethanol-induced chronic hepatitis. These findings suggest that Ich can thanh solution at 9.6 mL/kg/day exerts a hepatoprotective effect against ethanol-induced liver injury in experimental animals.
Article Details
Keywords
Ich can thanh, hepatoprotection, ethanol, Swiss mice
References
2. Huu Bich T, Thi Quynh Nga P, Ngoc Quang L, et al. Patterns of alcohol consumption in diverse rural populations in the Asian region. Global Health Action. 2009;2.
3. Iranpour A, Nakhaee N. A review of alcohol-related harms: A recent update. Addict health. 2019;11(2):129-137.
4. Porro C, Benameur T, Cianciulli A, et al. Functional and therapeutic potential of Cynara scolymus in health benefits. Nutrients. 2024;16(6):872.
5. Kim KH, Kim YH, Lee KR. Isolation of hepatoprotective phenylpropanoid from Lactuca indica. Natural product sciences. 2010;16:6-9.
6. Abenavoli L, Capasso R, Milic N, et al. Milk thistle in liver diseases: past, present, future. Phytotherapy Research. 2010;24(10):1423-1432.
7. Wang B, Gao X, Liu B, et al. Protective effects of curcumin against chronic alcohol-induced liver injury in mice through modulating mitochondrial dysfunction and inhibiting endoplasmic reticulum stress. Food & Nutrition Research. 2019;63:10.
8. Trần Công Luận. Tác dụng bảo vệ gan của viên nang đinh lăng (Polyscias fruticosa (L.) Harms) trên mô hình gây tổn thương gan mạn tính bằng ethanol. Tạp chí Nghiên cứu khoa học và Phát triển kinh tế Trường Đại học Tây Đô. 2017;2:132-140.
9. Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the worldwide. Journal of Hepatology. 2019;70(1):151-171.
10. Ambade A, Mandrekar P. Oxidative stress and inflammation: essential partners in alcoholic liver disease. International journal of hepatology. 2012;2012(1):853175.
11. Sakaguchi S, Takahashi S, Sasaki T, et al. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. Drug metabolism and pharmacokinetics. 2011;26(1):30-46.
12. Cordiano R, Di Gioacchino M, Mangifesta R, et al. Malondialdehyde as a potential oxidative stress marker for allergy-oriented diseases: An update. Molecules. 2023;28(16):5979.
13. Aguiar AS, Da-Silva VA, Boaventura GT. Can calories from ethanol contribute to body weight preservation by malnourished rats?. Brazilian Journal of Medical and Biological Research. 2004;37(6):841-6.
14. Brandon-Warner E, Schrum LW, Schmidt CM, et al. Rodent models of alcoholic liver disease: of mice and men. Alcohol. 2012;46(8):715-25.
15. Ngoc Khanh P, Katarina Bauerova, Manh Cuong N. Studies on hepatoprotective effects of Vietnamese medicinal plants. Vietnam journal of science and technology. 2023;61(5):725-750.
16. Peng JH, Cui T, Huang F, et al. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, kupffer cell activation, and endotoxin receptors expression. The journal of pharmacology and experimental therapeutics. 2013;344(3):646-654.
17. He YX, Liu MN, Wu H, et al. Puerarin: a hepatoprotective drug from bench to bedside. Chinese Medicine. 2024;19(1):139.